Michael Thomas Boyce-Jacino
Directeur Général chez QLIDA Diagnostics, Inc.
Profil
Michael Thomas Boyce-Jacino founded QLIDA Diagnostics, Inc., where he worked as Chief Executive Officer.
Dr. Boyce-Jacino also currently works at Aptatek Biosciences, Inc., as President & Chief Executive Officer and Princeton Biostrategy Group LLP, as Director.
Dr. Boyce-Jacino also formerly worked at Bionano Genomics, Inc., as President & Chief Executive Officer, Vortex BioSciences, Inc., as Chief Executive Officer, Beckman Coulter, Inc., as VP & Director-Global Genomics Research, PDS Operating Corp., as Director, Dalian Wanda Group Co., Ltd., as Director, NetScientific Plc, as Executive Director from 2013 to 2015, Optofluidics, Inc., as Director, Glycotest, Inc., as Director, Orchid Cellmark, Inc., as Chief Scientific Officer, Vice President & GM, and Molecular Tool, Inc., as President.
Dr. Boyce-Jacino received his undergraduate degree from the University of Wisconsin and doctorate degree from the University of Minnesota.
Postes actifs de Michael Thomas Boyce-Jacino
| Sociétés | Poste | Début |
|---|---|---|
QLIDA Diagnostics, Inc.
 QLIDA Diagnostics, Inc. Medical SpecialtiesHealth Technology QLIDA Diagnostics, Inc. develops and manufactures biomarker diagnostic tests. The private company is based in Philadelphia, PA. The company was founded by Michael Thomas Boyce-Jacino. Michael Thomas Boyce-Jacino has been the CEO since incorporation. | Directeur Général | - |
| Princeton Biostrategy Group LLP | Directeur/Membre du Conseil | - |
Aptatek Biosciences, Inc.
 Aptatek Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Aptatek Biosciences, Inc. is a company that develops home monitoring tools for chronic disease patients using novel aptamer chemistry. The company is based in Princeton, NJ. The company's mission is to empower individuals with chronic diseases to manage their health more effectively by combining cutting-edge aptamer technology, data-driven insights, and a patient-centric approach to revolutionize healthcare management. Aptatek Biosciences is at the forefront of revolutionizing phenylketonuria (PKU) monitoring and expanding to other chronic disease states. The company was founded by Tilla Worgall, Milan Stojanovic. The CEO is Michael Thomas Boyce-Jacino. | Directeur Général | - |
Anciens postes connus de Michael Thomas Boyce-Jacino
| Sociétés | Poste | Fin |
|---|---|---|
| NETSCIENTIFIC PLC | Directeur des opérations | - |
Vortex BioSciences, Inc.
 Vortex BioSciences, Inc. Medical SpecialtiesHealth Technology Vortex BioSciences, Inc. provides a solution for routine isolation and purification of Circulating Tumor Cells (CTC). It offers VTX-1, an automated system that isolates intact CTCs directly from whole blood with high recovery and high purity. The company was founded by Dino Di Carlo and Elodie Sollier and is headquartered in Pleasanton, CA. | Directeur Général | 31/12/2015 |
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Dalian Wanda Group Co., Ltd.
 Dalian Wanda Group Co., Ltd. Real Estate DevelopmentFinance Dalian Wanda Group Co., Ltd. engages in the provision of investment and business management services. It focuses on construction of commercial properties, operation of cultural enterprises, life insurance, and financial services. Its business includes commercial management group, cultural industry group, real estate group, and investment group. The company was founded by JianLin Wang in 1988 and is headquartered in Dalian, China. | Directeur/Membre du Conseil | - |
Molecular Tool, Inc.
 Molecular Tool, Inc. Packaged SoftwareTechnology Services Part of Laboratory Corp. of America Holdings, Molecular Tool, Inc. develops tools for analysis of DNA sequence variation. The company is based in Baltimore, MD. The company was founded by Philip Goelet. | President | - |
Formation de Michael Thomas Boyce-Jacino
| University of Wisconsin | Undergraduate Degree |
| University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIONANO GENOMICS, INC. | Health Technology |
| NETSCIENTIFIC PLC | Health Technology |
| Entreprise privées | 11 |
|---|---|
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Health Technology |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Commercial Services |
PDS Operating Corp.
 PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Health Technology |
Molecular Tool, Inc.
Molecular Tool, Inc. Packaged SoftwareTechnology Services Part of Laboratory Corp. of America Holdings, Molecular Tool, Inc. develops tools for analysis of DNA sequence variation. The company is based in Baltimore, MD. The company was founded by Philip Goelet. | Technology Services |
Dalian Wanda Group Co., Ltd.
Dalian Wanda Group Co., Ltd. Real Estate DevelopmentFinance Dalian Wanda Group Co., Ltd. engages in the provision of investment and business management services. It focuses on construction of commercial properties, operation of cultural enterprises, life insurance, and financial services. Its business includes commercial management group, cultural industry group, real estate group, and investment group. The company was founded by JianLin Wang in 1988 and is headquartered in Dalian, China. | Finance |
Optofluidics, Inc.
 Optofluidics, Inc. Medical SpecialtiesHealth Technology Optofluidics, Inc. operates as a scientific instrumentation company. It commercializes proprietary nano-technological devices to perform particle analysis and nano-manipulation applications for the life science and materials industries. The firm?s products include Hexpoint, NT Surface and Nano Tweezer. The company was founded by Bernardo Cordovez, Robert Hart and David Erickson in 2010 and is headquartered in Philadelphia, PA. | Health Technology |
QLIDA Diagnostics, Inc.
QLIDA Diagnostics, Inc. Medical SpecialtiesHealth Technology QLIDA Diagnostics, Inc. develops and manufactures biomarker diagnostic tests. The private company is based in Philadelphia, PA. The company was founded by Michael Thomas Boyce-Jacino. Michael Thomas Boyce-Jacino has been the CEO since incorporation. | Health Technology |
Vortex BioSciences, Inc.
Vortex BioSciences, Inc. Medical SpecialtiesHealth Technology Vortex BioSciences, Inc. provides a solution for routine isolation and purification of Circulating Tumor Cells (CTC). It offers VTX-1, an automated system that isolates intact CTCs directly from whole blood with high recovery and high purity. The company was founded by Dino Di Carlo and Elodie Sollier and is headquartered in Pleasanton, CA. | Health Technology |
Glycotest, Inc.
Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Technology |
Aptatek Biosciences, Inc.
Aptatek Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Aptatek Biosciences, Inc. is a company that develops home monitoring tools for chronic disease patients using novel aptamer chemistry. The company is based in Princeton, NJ. The company's mission is to empower individuals with chronic diseases to manage their health more effectively by combining cutting-edge aptamer technology, data-driven insights, and a patient-centric approach to revolutionize healthcare management. Aptatek Biosciences is at the forefront of revolutionizing phenylketonuria (PKU) monitoring and expanding to other chronic disease states. The company was founded by Tilla Worgall, Milan Stojanovic. The CEO is Michael Thomas Boyce-Jacino. | Electronic Technology |
| Princeton Biostrategy Group LLP |
